Expert Interview
A Third View: Delving into the phase 3 data published in the New England Journal of Medicine on Tolebrutinib in patients with multiple sclerosis
Ticker(s): SNY
Institution: Baylor College of Medicine
- Neurologist specializing in Multiple Sclerosis, Optic Neuritis, Demyelinating Diseases, Cerebral and spinal vascular disorders.
- Currently manages 20 patients with Multiple Sclerosis.
- Able to discuss the Phase 3 DAYBREAK of Zeposia for treatment of Multiple Sclerosis.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
